GlassScriptPhysician profile
Karen V Warner
NPI 1336245737
$3,783.51
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $1,193 · 2021: $1,262.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $580.00 | 2019-2021 | |
| Allergan, INC. | $400.53 | 2019-2020 | |
| Abbvie INC. | $396.97 | 2019-2021 | |
| Lilly USA, LLC | $384.72 | 2019-2021 | |
| Novo Nordisk INC | $300.69 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.62 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $232.12 | 2019-2021 | |
| Glaxosmithkline, LLC. | $230.69 | 2019-2021 | |
| Pfizer INC. | $186.17 | 2019-2021 | |
| Astellas Pharma US INC | $112.00 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.83 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $84.45 | 2019-2021 | |
| Amgen INC. | $83.55 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $72.85 | 2019-2020 | |
| Circassia INC. | $54.12 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $54.08 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $44.57 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $37.33 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.03 | 2019 | |
| Bausch Health US, LLC | $28.61 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.43 | 2021 | |
| Optinose US, INC. | $14.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.57 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.